Terms: = Skin cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Prognosis
175 results:
1. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
2. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced nras-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.
Kim HJ; Kim YH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
5. Combined PDE4+MEK inhibition shows antiproliferative effects in nrasQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
6. Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent nras and CTNNB1 mutations.
Tsushima N; Kano S; Hatanaka KC; Suzuki T; Hamada S; Idogawa H; Nakamaru Y; Suzuki M; Hatanaka Y; Homma A
Auris Nasus Larynx; 2024 Apr; 51(2):313-319. PubMed ID: 37953090
[TBL] [Abstract] [Full Text] [Related]
7. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract] [Full Text] [Related]
8. Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.
Sergi MC; Filoni E; Triggiano G; Cazzato G; Internò V; Porta C; Tucci M
Curr Oncol Rep; 2023 Nov; 25(11):1247-1258. PubMed ID: 37773078
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
10. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract] [Full Text] [Related]
14. Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies.
Zob DL; Augustin I; Caba L; Panzaru MC; Popa S; Popa AD; Florea L; Gorduza EV
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614156
[TBL] [Abstract] [Full Text] [Related]
15. Clinical features and response to systemic therapy in nras-mutant Chinese melanoma patients.
Wang J; Jiang H; Huang F; Li D; Wen X; Ding Q; Ding Y; Zhang X; Li J
J Cancer Res Clin Oncol; 2023 Feb; 149(2):701-708. PubMed ID: 36454283
[TBL] [Abstract] [Full Text] [Related]
16. Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Mattila KE; Mäkelä S; Kytölä S; Andersson E; Vihinen P; Ramadan S; Skyttä T; Tiainen L; Vuoristo MS; Tyynelä-Korhonen K; Koivunen J; Kohtamäki L; Aittomäki K; Hernberg M
Acta Oncol; 2022 Oct; 61(10):1263-1267. PubMed ID: 36307938
[TBL] [Abstract] [Full Text] [Related]
17. Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.
García-Gutiérrez L; Fallahi E; Aboud N; Quinn N; Matallanas D
Cell Death Dis; 2022 Aug; 13(8):692. PubMed ID: 35941108
[TBL] [Abstract] [Full Text] [Related]
18. Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma.
Mao R; Ren Z; Yang F; Yang P; Zhang T
Cancer Sci; 2022 Nov; 113(11):3947-3959. PubMed ID: 35848898
[TBL] [Abstract] [Full Text] [Related]
19.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
[TBL] [Abstract] [Full Text] [Related]
[Next]